Your Impact
Thank you for helping to fund research that saves lives.
Today 18 Australian women will hear the words:
"You have gynaecological cancer".
Cherish Women’s Cancer Foundation raises awareness and funds vital clinical research that results in kinder treatments and improved outcomes for women and girls with gynaecological cancer.
Each year over 6,700 Australian women and girls are diagnosed with gynaecological cancer and this number is increasing annually and almost a third will not survive their disease.
Gynaecological cancers (ovarian, endometrial, cervical and vulvar) are the third most common cancer diagnosed in Australian women.
Cherish has a clear vision to transform the standard care of women and girls diagnosed with gynaecological cancer from rigid, institution-centred methods to a contemporary, personalised informed approach with research to be conducted and then implemented into clinical practice.
Cherish aims to fund medical research and care that optimises gynaecological cancer early detection, diagnosis, treatment, survival rates and quality of life.
But we can't do it alone. Your support and assistance with funding enables Cherish to support breakthroughs and success in medical research for gynaecological cancer.
Research Projects
Research projects that Cherish has helped fund.
Femme Molecular
A non-surgical alternative to hysterectomy for the treatement of endometrial cancer.
ENDO-3
A world-first randomised clinical trial investigating the risks and benefits of sentinel node biopsy.
FEMME
Improving the treatment for women with early-stage endometrial cancer.
Pre-ANVU
Each year, approximately 400 Australian women are diagnosed with vulvar cancer. Pre-ANVU is a small study of 50 women that aims to review the feasibility of using ultrasound to check the groin lymph nodes for cancer.
